Myasthenia Gravis: Clinical, Immunological, and Therapeutic Advances

Overview

Journal Acta Neurol Scand

Specialty Neurology

Date 2005 Jan 13

PMID 15644074

Citations 18

Authors

F Romi

N E Gilhus

J A Aarli

Affiliations

Soon will be listed here.

Abstract

We give an update on clinical, immunological, and therapeutic advances in the field of myasthenia gravis, including a summary of suggested therapeutic recommendations.

Citing Articles

Social support and medication adherence among adult myasthenia gravis patients in China: the mediating role of mental health and self-efficacy.

Yu J, Xie L, Chen S, Fang Z, Zhu L, Zhang H Orphanet J Rare Dis. 2024; 19(1):143.

PMID: 38576038 PMC: 10993533. DOI: 10.1186/s13023-024-03145-6.

Altered serum levels of cytokines in patients with myasthenia gravis.

Wei S, Yang C, Si W, Dong J, Zhao X, Zhang P Heliyon. 2024; 10(1):e23745.

PMID: 38192761 PMC: 10772159. DOI: 10.1016/j.heliyon.2023.e23745.

LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis.

Wang X, Zhang H, Lu X, Li S, Kong X, Liu L PeerJ. 2022; 10:e13454.

PMID: 35602889 PMC: 9121865. DOI: 10.7717/peerj.13454.

Myasthenia Gravis Following Excision of a Large Thymoma.

Mittal G, Naik B, Sundriyal D Indian J Surg Oncol. 2021; 12(2):446-449.

PMID: 34295095 PMC: 8272761. DOI: 10.1007/s13193-021-01326-4.

Case Series: Clinical Impact of Plasmapheresis and Thymectomy on Early-Onset Myasthenia Gravis.

Siahaan Y, Ketaren R, Pangestu A, Hartoyo V Case Rep Neurol. 2021; 13(1):1-8.

PMID: 33613237 PMC: 7879280. DOI: 10.1159/000511300.